View Item 

Show simple item record

Prevalence of the HOXB13   G84E prostate cancer risk allele in men treated with radical prostatectomy
dc.contributor.authorBeebe‐dimmer, Jennifer L.en_US
dc.contributor.authorIsaacs, William B.en_US
dc.contributor.authorZuhlke, Kimberly A.en_US
dc.contributor.authorYee, Ceciliaen_US
dc.contributor.authorWalsh, Patrick C.en_US
dc.contributor.authorIsaacs, Sarah D.en_US
dc.contributor.authorJohnson, Anna M.en_US
dc.contributor.authorEwing, Charles E.en_US
dc.contributor.authorHumphreys, Elizabeth B.en_US
dc.contributor.authorChowdhury, Wasim H.en_US
dc.contributor.authorMontie, James E.en_US
dc.contributor.authorCooney, Kathleen A.en_US
dc.date.accessioned2014-05-23T15:59:32Z
dc.date.availableWITHHELD_13_MONTHSen_US
dc.date.available2014-05-23T15:59:32Z
dc.date.issued2014-05en_US
dc.identifier.citationBeebe‐dimmer, Jennifer L. ; Isaacs, William B.; Zuhlke, Kimberly A.; Yee, Cecilia; Walsh, Patrick C.; Isaacs, Sarah D.; Johnson, Anna M.; Ewing, Charles E.; Humphreys, Elizabeth B.; Chowdhury, Wasim H.; Montie, James E.; Cooney, Kathleen A. (2014). "Prevalence of the HOXB13 â G84E prostate cancer risk allele in men treated with radical prostatectomy." BJU International (5): 830-835.en_US
dc.identifier.issn1464-4096en_US
dc.identifier.issn1464-410Xen_US
dc.identifier.urihttps://hdl.handle.net/2027.42/106912
dc.publisherWiley Periodicals, Inc.en_US
dc.subject.otherFamily Historyen_US
dc.subject.otherHOXB13en_US
dc.subject.otherProstate Canceren_US
dc.subject.otherGenetic Epidemiologyen_US
dc.titlePrevalence of the HOXB13   G84E prostate cancer risk allele in men treated with radical prostatectomyen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelInternal Medicine and Specialtiesen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/106912/1/bju12522.pdf
dc.identifier.doi10.1111/bju.12522en_US
dc.identifier.sourceBJU Internationalen_US
dc.identifier.citedreferenceLin X, Qu L, Chen Z et al. A novel germline mutation in HOXB13 is associated with prostate cancer risk in Chinese men. Prostate 2012; 73: 169 – 175en_US
dc.identifier.citedreferenceStanford JL, Ostrander EA. Familial prostate cancer. Epidemiol Rev 2001; 23: 19 – 23en_US
dc.identifier.citedreferenceEwing CM, Ray AM, Lange EM et al. Germline mutations in HOXB13 and prostate‐cancer risk. N Engl J Med 2012; 366: 141 – 149en_US
dc.identifier.citedreferenceKarlsson R, Aly M, Clements M et al. A population‐based assessment of germline HOXB13 G84E mutation and prostate cancer risk. Eur Urol 2012; 65: 169 – 176en_US
dc.identifier.citedreferenceStott‐Miller M, Karyadi DM, Smith T et al. HOXB13 mutations in a population‐based, case‐control study of prostate cancer. Prostate 2012; 73: 634 – 641en_US
dc.identifier.citedreferenceXu J, Lange EM, Lu L et al. HOXB13 is a susceptibility gene for prostate cancer: results from the International Consortium for Prostate Cancer Genetics (ICPCG). Hum Genet 2012; 132: 5 – 14en_US
dc.identifier.citedreferenceBreyer JP, Avritt TG, McReynolds KM, Dupont WD, Smith JR. Confirmation of the HOXB13 G84E germline mutation in familial prostate cancer. Cancer Epidemiol Biomarkers Prev 2012; 21: 1348 – 1353en_US
dc.identifier.citedreferenceAkbari MR, Trachtenberg J, Lee J et al. Association between germline HOXB13 G84E mutation and risk of prostate cancer. J Natl Cancer Inst 2012; 104: 1260 – 1262en_US
dc.identifier.citedreferenceLaitinen VH, Wahlfors T, Saaristo L et al. HOXB13 G84E mutation in Finland; population‐based analysis of prostate, breast and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 2013; 22: 452 – 460en_US
dc.identifier.citedreferenceLange EM, Gillanders EM, Davis CC et al. Genome‐wide scan for prostate cancer susceptibility genes using families from the University of Michigan Prostate Cancer Genetics Project finds evidence for linkage on chromosome 17 near BRCA1. Prostate 2003; 57: 326 – 334en_US
dc.identifier.citedreferenceWitte JS, Mefford J, Plummer SJ et al. HOXB13 mutation and prostate cancer: studies of siblings and aggressive disease. Cancer Epidemiol Biomarkers Prev 2013; 22: 675 – 680en_US
dc.identifier.citedreferenceChen Z, Greenwood C, Isaacs WB et al. The G84E mutation of HOXB13 is associated with increased risk for prostate cancer: results from the REDUCE trial. Carcinogenesis 2013; 34: 1260 – 1264en_US
dc.identifier.citedreferenceShang Z, Zhu S, Zhang H, Li L, Niu Y. Germline homeobox B13 (HOXB13) G84E mutation and prostate cancer risk in European descendants: a meta‐analysis of 24 213 cases and 73 631 controls. Eur Urol 2013; 64: 173 – 176en_US
dc.identifier.citedreferenceMacinnis RJ, Severi G, Baglietto L et al. Population‐based estimate of prostate cancer risk for carriers of the HOXB13 missense mutation G84E. Plos ONE 2013; 8: e54727en_US
dc.identifier.citedreferenceSchroeck FR, Zuhlke KA, Siddiqui J, Siddiqui R, Cooney KA, Wei JT. Testing for the recurrent HOXB13 G84E germline mutation in men with clinical indications for prostate biopsy. J Urol 2012; 189: 849 – 853en_US
dc.identifier.citedreferenceAkbari MR, Kluzniak W, Rodin R et al. The HOXB13 p.Gly84Glu mutation is not associated with the risk of breast cancer. Breast Cancer Res Treat 2012; 136: 907 – 909en_US
dc.identifier.citedreferenceAlanee S, Couch F, Offit K. Association of a HOXB13 variant with breast cancer. N Engl J Med 2012; 367: 480 – 481en_US
dc.identifier.citedreferenceShah N, Sukumar S. The Hox genes and their roles in oncogenesis. Nat Rev Cancer 2010; 10: 361 – 371en_US
dc.identifier.citedreferenceZeltser L, Desplan C, Heintz N. Hoxb‐13: a new Hox gene in a distant region of the HOXB cluster maintains colinearity. Development 1996; 122: 2475 – 2484en_US
dc.identifier.citedreferenceHuang L, Pu Y, Hepps D, Danielpour D, Prins GS. Posterior Hox gene expression and differential androgen regulation in the developing and adult rat prostate lobes. Endocrinology 2007; 148: 1235 – 1245en_US
dc.identifier.citedreferenceJung C, Kim RS, Zhang HJ, Lee SJ, Jeng MH. HOXB13 induces growth suppression of prostate cancer cells as a repressor of hormone‐activated androgen receptor signaling. Cancer Res 2004; 64: 9185 – 9192en_US
dc.identifier.citedreferenceNorris JD, Chang CY, Wittmann BM et al. The homeodomain protein HOXB13 regulates the cellular response to androgens. Mol Cell 2009; 36: 405 – 416en_US
dc.identifier.citedreferenceCooperberg MR, Pasta DJ, Elkin EP et al. The University of California, San Francisco Cancer of the Prostate Risk Assessment score: a straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy. J Urol 2005; 173: 1938 – 1942en_US
dc.identifier.citedreferenceLoeb S, Carvalhal GF, Kan D, Desai A, Catalona WJ. External validation of the cancer of the prostate risk assessment (CAPRA) score in a single‐surgeon radical prostatectomy series. Urol Oncol 2012; 30: 584 – 589en_US
dc.identifier.citedreferenceWilt TJ, Brawer MK, Jones KM et al. Radical prostatectomy versus observation for localized prostate cancer. N Engl J Med 2012; 367: 203 – 213en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
bju12522.pdf
Size:
133.4KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.